Both Mounjaro and Wegovy are cleared for weight loss in combination with ... vaccines to adults aged 50-64 9:39 AM UTC ...

Type 2 diabetes is a risk factor for dementia and Alzheimer’s. Novo Nordisk, which makes Ozempic and Wegovy, is running two ...

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...

Novo Nordisk A/S (NYSE: NVO), the company behind Ozempic, recently announced that its oral semaglutide (Rybelsus®) (the active ingredient in Ozempic and Wegovy) reduced the risk of major adverse ...

Health and wellness companies are responding in kind, with recent market developments coming from: PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF), Novo Nordisk A/S (NYSE: NVO), Eli Lilly and Company ...